HIMSS TV
HIMSS24
The 2024 HIMSS Global Health Conference & Exhibition shows how major industry issues are being tackled, looks at who's done it before and how people can learn from each other, and lets them hear from experts, says Hal Wolf, president and CEO of HIMSS.
Qualified health information networks, or QHINs, form a national network under TEFCA which has the reach to bring on all healthcare entities in the country, says Dr. John Blair, CEO of MedAllies, a designated QHIN.
AI Co-Pilot can listen to healthcare communication, offer feedback for better patient decisions and help with documentation, says Lars Maaløe, Corti cofounder and chief technology officer.
HIMSS24
Heading into HIMSS24, Prashant Natarajan, vice president of strategy and products at H2O.ai, says he's looking forward to hearing strategies and working together within the HIMSS framework.
Sumit Nagpal, CEO of Cherish Health, said technology that can track people's movements inside the home has preventive benefits to move the dial on healthcare costs.
HIMSS24
Change management barriers include reimagining how health systems communicate with physicians and nursing staff, say Cleveland Clinic ACO's Dr. Jessica Hohman and Cleveland Clinic Florida's Dr. Richard Rothman, who will be speaking at HIMSS24.
Gabriel Seidman, director of policy at Ellison Institute of Technology and colleagues wrote a paper on what the federal government and states can do to build a nationwide ecosystem to address homelessness and other health issues.
HIMSS24
Longtime CIOs Cris Ross and Ed Marx will talk at HIMSS24 about their own care journeys and their book, "Diagnosed: An Insider's Guide to Your Healthcare Journey," with author proceeds benefiting cancer research at the Mayo Clinic.
Dr. Peter Bonis, chief medical officer at Wolters Kluwer Health, says the acquisition of drug-diversion company Invistics is helping to route appropriate medications to the right patients.
HIMSS24
Bridging the gap between research and clinical practice through digital health technologies is the subject of a HIMSS24 session with the Mayo Clinic's SaMD regulatory affairs manager, Brenna Loufek.